Group One Trading’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
CCC
ACM
OIA
AIC
KCM
Group One Trading's ABEO Position: Q2 2026 in Review
Group One Trading increased its Abeona Therapeutics (ABEO) stake by 17% in Q2 2026, buying an estimated $195K and bringing the position to 245,046 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2489.
Group One Trading first reported a position in ABEO in Q3 2015 and has held it in 27 quarters since. The position peaked at $1.81M in Q3 2017. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.
- Group One Trading held 245,046 shares of Abeona Therapeutics worth $1.51M as of Q2 2026.
- Group One Trading bought 35,439 Abeona Therapeutics shares in Q2 2026, an estimated $195K.
- Abeona Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2489 holding.
- Group One Trading first reported a position in Abeona Therapeutics in Q3 2015 and has held it in 27 quarters since.
- Group One Trading's Abeona Therapeutics position peaked at $1.81M in Q3 2017.
- 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.